Yang Shi
Corporate Officer/Principal bei EVEREST MEDICINES LIMITED
Profil
Yang Shi is currently the Director at EverNov Medicines (Zhuhai Hengqin) Co. Ltd.
and the Chief Medical Officer-Oncology at Everest Medicines Ltd.
She previously worked as the Director-Project Development at Boehringer Ingelheim International Trading (Shanghai) Co. Ltd.
and Boehringer Ingelheim International GmbH from 2010 to 2015.
From 2015 to 2019, she was the Head-China Clinical Development at Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.
Prior to that, she worked as the Senior Manager-Oncology at Pfizer Investment Co. Ltd.
from 2005 to 2010.
Ms. Shi received her undergraduate degree from Capital Medical University in 1998 and her graduate degree from the Academy of Military Medical Sciences in 2002.
Aktive Positionen von Yang Shi
| Unternehmen | Position | Beginn |
|---|---|---|
| EVEREST MEDICINES LIMITED | Corporate Officer/Principal | 01.02.2019 |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von Yang Shi
| Unternehmen | Position | Ende |
|---|---|---|
Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.
 Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. develops, manufactures, and wholesales pharmaceutical products. The private company is based in Beijing, China. | Corporate Officer/Principal | 01.02.2019 |
| Boehringer Ingelheim International Trading (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01.02.2015 |
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Corporate Officer/Principal | 01.02.2015 |
Pfizer Investment Co. Ltd.
 Pfizer Investment Co. Ltd. Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Investment Co. Ltd. is a Chinese company that provides investment and investments consulting services. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01.09.2010 |
Ausbildung von Yang Shi
| Capital Medical University | Undergraduate Degree |
| Academy of Military Medical Sciences | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVEREST MEDICINES LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Boehringer Ingelheim International Trading (Shanghai) Co. Ltd. | |
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Health Technology |
Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.
Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. develops, manufactures, and wholesales pharmaceutical products. The private company is based in Beijing, China. | Health Technology |
Pfizer Investment Co. Ltd.
Pfizer Investment Co. Ltd. Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Investment Co. Ltd. is a Chinese company that provides investment and investments consulting services. The private company is based in Shanghai, China. | Finance |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. |
